semaglutide shortage fda tirzepatide 🚨 FDA Ends Shortage The FDA has officially declared an end to Explainer: What's behind the scramble

Its development focused specifically on balancing the appetite-suppressing effects of GLP-1 receptor activation with the metabolic acceleration provided by glucagon receptor stimulation

It is the first drug to work on both of these

On bivariate analysis, patients with a CAO were more likely to have a history of prior abdominal surgery (86.3% vs 70.5%, p = 0.04) and were less likely to have undergone a preoperative CT scan (27.5% vs 45.5%, p = 0.04)

However, it would be best to take it at the same time each day to avoid the chances of missing a dose

It also aids in weight loss, which is not a common feature of most diabetes medications.